Molnupiravir Clinical Trials
6 recruitingDrug
Phase 24Phase 32Phase 11
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled218 locationsNCT06667700
Recruiting
Phase 2
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
COVID-19
University of Oxford3,800 enrolled7 locationsNCT05041907
Recruiting
Phase 2
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
InfluenzaInfluenza, Human
University of Oxford3,000 enrolled4 locationsNCT05648448
Recruiting
Phase 1Phase 2
AGILE (Early Phase Platform Trial for COVID-19)
University of Liverpool600 enrolled6 locationsNCT04746183
Recruiting
Phase 2
Assessing Antiviral Treatments in Early Symptomatic RSV
University of Oxford1,000 enrolled2 locationsNCT06488300
Recruiting
Phase 3
Randomised Evaluation of COVID-19 Therapy
Severe Acute Respiratory Syndrome
University of Oxford70,000 enrolled7 locationsNCT04381936